VaramirStart free · no cardSign in
ZVRA as of Oct 30 · 22:33 ET
ZVRANasdaqPharmaceutical Preparations

Zevra Therapeutics, Inc. · Brief

Next report

4 days

Nov 4 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±16.3%
avg realized
±9.0%
Nov 12 '24±10.2%▲+1.05%×0.10
Mar 11 '25±26.6%▼−1.86%×0.07
May 13 '25±10.3%▲+3.43%×0.33
Aug 12 '25±12.6%▼−19.81%×1.58
Q3 FY25±14.7%▼−9.73%×0.66
Q1 FY26±29.2%▲+21.27%×0.73
May 6 '26±13.3%▼−2.22%×0.17
Q2 FY26±13.4%▲+12.82%×0.96
quarterimplied−30%0+30%realized×
Q2 FY26±13.4%▲+12.82%×0.96
May '26±13.3%▼−2.22%×0.17
Q1 FY26±29.2%▲+21.27%×0.73
Q3 FY25±14.7%▼−9.73%×0.66
Aug '25±12.6%▼−19.81%×1.58
May '25±10.3%▲+3.43%×0.33
2 older reports
Mar '25±26.6%▼−1.86%×0.07
Nov '24±10.2%▲+1.05%×0.10
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2

6disclosed supplier and customer ties in SEC filingsSEC filings
156managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2

3tracked funds holding ZVRAN-PORT · Aug 31 '26
8 of 22of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ZVRA report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±28.9% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.